Scandinavian Journal of Rheumatology

Papers
(The H4-Index of Scandinavian Journal of Rheumatology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study52
Orbital and periorbital inflammation in VEXAS syndrome19
Pamidronate in chronic non-bacterial osteomyelitis: a randomized, double-blinded, placebo-controlled pilot trial17
Large-vessel giant cell arteritis after COVID-19 vaccine17
Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity17
Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial16
Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review14
Association between inflammasome-related polymorphisms and psoriatic arthritis13
Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–201112
The validity of rheumatoid arthritis diagnoses in Finnish biobanks11
Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status11
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents11
Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study11
Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain11
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients11
0.050611972808838